Clicky

Amphastar Pharmaceuticals, Inc.(AMPH)

Description: Amphastar Pharmaceuticals, Inc., a generic and specialty pharmaceutical company, engages in the discovery, development, manufacture, and marketing of generic and proprietary pharmaceuticals, delivery systems, and active pharmaceutical ingredients. The company focuses on injectable, inhalation, and other categories of pharmaceutical products. Its products include Enoxaparin Sodium Injection, which is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis; Amphadase, a protein enzyme that is prepared from a highly purified bovine testicular hyaluronidase; Cortrosyn for Injection, a diagnostic agent that is used in the screening of patients presumed to have adrenocortocal insufficiency; and prefilled disposable emergency syringes for crash cart use. The company's products also include Lidocaine HCl Jelly, a preservative-free topical local anesthetic agent that is provided in a prefilled syringe; Naloxone HCl Injection for the complete or partial reversal of narcotic depression and diagnosis of suspected acute opioid overdose; and Phytonadione Injection (Vitamin K1) for newborns. In addition, it markets its drug development pipeline and patented technologies. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California with manufacturing subsidiaries/facilities in South El Monte, California; and West Roxbury and Canton, Massachusetts.


Keywords: Medicine Pharmaceutical Pharmaceutical Products Pharmacology Active Pharmaceutical Ingredients Medical Equipment Drug Development Vitamins Depression Opioids Syringe Injection Drug Paraphernalia Thrombosis Heroin Veins Deep Vein Thrombosis Naloxone Lidocaine Reversal Xone Pulmonary Embolism Hyaluronidase Local Anesthetic Amphastar Pharmaceuticals

Home Page: www.amphastar.com

AMPH Technical Analysis

11570 6th Street
Rancho Cucamonga, CA 91730
United States
Phone: 909 980 9484


Officers

Name Title
Dr. Ziping Luo Ph.D. Chairman, Chief Scientist & COO
Dr. Yongfeng Zhang Ph.D. Co-Founder, Pres, CEO, Chief Scientific Officer & Director
Mr. William J. Peters M.B.A. CFO, Exec. VP of Fin., Treasurer & Director
Mr. Jacob Liawatidewi M.B.A. Exec. VP of Sales, Marketing & Corp. Admin. Center, Corp. Sec. and Director
Mr. Rong Zhou M.S. Exec. VP of Production Center
Dan Dischner M.B.A. VP of HR & Corp. Communication
Tony Marrs M.B.A., M.P.H. Sr. VP of Regulatory Affairs & Clinical Operations
Mr. Peter Langosh VP of Operational Improvement and VP of Internal Audit

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 18.8792
Price-to-Book MRQ: 2.7899
Price-to-Sales TTM: 2.839
IPO Date: 2014-06-25
Fiscal Year End: December
Full Time Employees: 1761
Back to stocks